Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
CROSS-REFERENCE TO RELATED APPLICATIONS
This application is a .sctn.371 national stage entry of International Application No. PCT/IB2013/001375, filed Jun. 28, 2013, which claims priority to Tunisian Patent Application No. TN 2012/0343 filed Jun. 29, 2012, the entire contents of which an
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
SUMMARY OF THE INVENTION
This invention is concerned with the use of angiotensin converting enzyme (ACE) inhibitors in the treatment of senile macular degeneration, a leading cause of visual diminution in the elderly.
BACKGROUND OF THE INVENTION
Senile macular degeneration is a poorly characterized
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
BACKGROUND OF INVENTION
It is currently believed that the diseases known as "autoimmune" diseases are caused by the body's immune system attacking the body itself. But I have discovered that these so-called "autoimmune" diseases are actually caused by stealthy intra-cellular bacteria. I have
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
FIELD OF THE INVENTION
The present invention relates to therapeutic agents that are angiotensin II (AII) receptor antagonists useful in the treatment of macular degeneration.
BACKGROUND OF THE INVENTION
Interruption of the renin-angiotensin system (RAS) with converting enzyme inhibitors, such as
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
This application is also related to PCT Application PCT/US14/30071, filed Mar. 15, 2014, the entire contents of which application are incorporated by reference in its entirety.
FIELD OF THE INVENTION
This invention relates to methods, compounds and compositions for the treatment of musculoskeletal
Korraldage oma huvisid ja hoidke end kursis uudisteuuringute, kliiniliste uuringute ja patentidega
Sisestage sümptom või haigus ja lugege ravimtaimede kohta, mis võivad aidata, tippige ürdi ja vaadake haigusi ja sümptomeid, mille vastu seda kasutatakse. * Kogu teave põhineb avaldatud teaduslikel uuringutel